dallas semaglutide gastric stasis lawsuit in Semaglutide Lawsuit Filed Against Ozempic & Wegovy Makers The Race to Beat Ozempic

Glucose-Dependent Insulinotropic Polypeptide in Incretin Physiology: Role in Health and Disease

These tumours should be managed similarly to other MelTUMPs (melanocytomas)

A Major Breakthrough in GLP-1 Drug Delivery On January 12, 2026, Chinas Center for Drug Evaluation (CDE) announced that Shiling Pharmas #semaglutide nasal spray has been approved to enter clinical trials for long-term weight management in adults (obesity and overweight patients with weight-related comorbidities)

GLP-1 Natural Alternatives: Supporting Metabolic Health Beyond Medications GLP-1 Natural Alternatives: Supporting Metabolic Health Beyond Medications | GLP-1 Natural Alternatives: Supporting Metabolic Health Beyond Medications GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have transformed the landscape of type 2 diabetes and obesity care

Extreme vulnerability of IDH1 mutant cancers to NAD+ depletion